Tools and Strategies Driving Cancer Immunotherapy

The Scientist brings together a panel of experts who will delve into the hope and hype in an effort to educate the audience about the new findings in cancer immunotherapy.

By | February 20, 2014

The Scientist brings together a panel of experts who will delve into the hope and hype in an effort to educate the audience about the new findings in cancer immunotherapy.

A number of labs in the pharma/biotech industry and in academia are now focusing their efforts on new ways to modulate the immune system to target cancer. Advances, both in understanding immune pathways and in developing tools to target and exploit these pathways, have led to remarkable progress in this relatively new field. The Scientist brings together a panel of experts who will delve into the hope and hype in an effort to educate the audience about the new findings in cancer immunotherapy. Attendees can interact with the experts during the live webinar by asking questions and sharing their experiences on this topic.

Topics to be covered:

  • Basic concepts underlying immunomodulation for oncology
  • New drug entities: immunomodulatory agents, vaccines, monoclonal antibodies, and more
  • Challenges in drug development
  • New tools for screening and validation
  • Use of biomarkers for targeted therapies

Meet the Speakers:

Dr. Jedd Wolchok
Chief, Melanoma & Immunotherapeutics Service
Memorial Sloan-Kettering Cancer Center

 

 

Dr. Tibor Keler
Senior Vice President and Chief Scientific Officer
Celldex Therapeutics

RocklandLonza

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Publishers’ Legal Action Advances Against Sci-Hub
  2. Decoding the Tripping Brain
  3. Metabolomics Data Under Scrutiny
    Daily News Metabolomics Data Under Scrutiny

    Out of 25,000 features originally detected by metabolic profiling of E. coli, fewer than 1,000 represent unique metabolites, a study finds.

  4. Do Microbes Trigger Alzheimer’s Disease?
AAAS